Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | TACR1 | P25103 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6173692 | 1.00 | AGTR2 (0.35) | AGTR2SLC6A2SLC6A4OPRM1OPRL1 | |
| SCHEMBL6171088 | 1.00 | AGTR2 (0.35) | AGTR2SLC6A2SLC6A4OPRM1OPRL1 | |
| SCHEMBL6172548 | 0.80 | EPHX2 (0.38) | LMNAEPHX2ACHE | |
| SCHEMBL6172595 | 0.80 | EPHX2 (0.38) | LMNAEPHX2ACHE | |
| SCHEMBL4027422 | 0.71 | SLC6A2 (0.41) | SLC6A2SLC6A4OPRM1OPRL1LMNA | |
| SCHEMBL4028340 | 0.71 | SLC6A2 (0.41) | SLC6A2SLC6A4OPRM1OPRL1LMNA | |
| SCHEMBL4027425 | 0.71 | SLC6A2 (0.41) | SLC6A2SLC6A4OPRM1OPRL1LMNA | |
| SCHEMBL6173844 | 0.71 | PPARA (0.38) | LMNAEPHX2ACHE | |
| SCHEMBL4028380 | 0.70 | L3MBTL1 (0.43) | SLC6A2SLC6A4OPRM1OPRL1TACR1 | |
| SCHEMBL4029654 | 0.70 | L3MBTL1 (0.43) | SLC6A2SLC6A4OPRM1OPRL1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569934-A2 | CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004055010-A2 | CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-07-01 | — | — | WO | disclosed |